IDEAS home Printed from https://ideas.repec.org/a/abf/journl/v29y2020i4p22597-22603.html
   My bibliography  Save this article

COVID-19 Immunotherapy- Novel Humanized 47D11 Monoclonal Antibody

Author

Listed:
  • Basma H Marghani

    (Department of Physiology, Faculty of Veterinary Medicine, Mansoura University, Egypt)

Abstract

SARS-CoV-2 was appeared firstly in Wuhan, China in December 2019, then spread rapidly to the other countries all over the world...

Suggested Citation

  • Basma H Marghani, 2020. "COVID-19 Immunotherapy- Novel Humanized 47D11 Monoclonal Antibody," Biomedical Journal of Scientific & Technical Research, Biomedical Research Network+, LLC, vol. 29(4), pages 22597-22603, August.
    • Handle: RePEc:abf:journl:v:29:y:2020:i:4:p:22597-22603
    DOI: 10.26717/BJSTR.2020.29.004828
    as

    Download full text from publisher

    File URL: https://biomedres.us/pdfs/BJSTR.MS.ID.004828.pdf
    Download Restriction: no
    File URL: https://biomedres.us/fulltexts/BJSTR.MS.ID.004828.php
    Download Restriction: no
    File URL: https://libkey.io/10.26717/BJSTR.2020.29.004828?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. David Cyranoski, 2020. "This scientist hopes to test coronavirus drugs on animals in locked-down Wuhan," Nature, Nature, vol. 577(7792), pages 607-607, January.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Hossein Hozhabri & Francesca Piceci Sparascio & Hamidreza Sohrabi & Leila Mousavifar & René Roy & Daniela Scribano & Alessandro De Luca & Cecilia Ambrosi & Meysam Sarshar, 2020. "The Global Emergency of Novel Coronavirus (SARS-CoV-2): An Update of the Current Status and Forecasting," IJERPH, MDPI, vol. 17(16), pages 1-35, August.

    More about this item

    Keywords

    COVID-19; Immunotherapy; Full-Length Humanized Monoclonal Antibodies; ACE Inhibitor;
    All these keywords.

    JEL classification:

    • R00 - Urban, Rural, Regional, Real Estate, and Transportation Economics - - General - - - General
    • Z0 - Other Special Topics - - General

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:abf:journl:v:29:y:2020:i:4:p:22597-22603. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Angela Roy (email available below). General contact details of provider: .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.